Dopaminergic medication reduces striatal sensitivity to negative outcomes in Parkinson’s disease

Reduced levels of dopamine in Parkinson’s disease contribute to changes in learning, resulting from the loss of midbrain neurons that transmit a dopaminergic teaching signal to the striatum. Dopamine medication used by patients with Parkinson’s disease has previously been linked to behavioural chang...

Descripción completa

Detalles Bibliográficos
Autores principales: McCoy, Brónagh, Jahfari, Sara, Engels, Gwenda, Knapen, Tomas, Theeuwes, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6821230/
https://www.ncbi.nlm.nih.gov/pubmed/31603493
http://dx.doi.org/10.1093/brain/awz276

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6821230/
https://www.ncbi.nlm.nih.gov/pubmed/31603493
http://dx.doi.org/10.1093/brain/awz276

Ejemplares similares